| E-IJD-RESIDENTS' PAGE |
|
| Year : 2015 | Volume
: 60
| Issue : 4 | Page : 419 |
|
|
Vorinostat-An overview
Aditya Kumar Bubna
Consultant Dermatologist, Kedar Hospital, Chennai, Tamil Nadu, India
Correspondence Address:
Dr. Aditya Kumar Bubna
Kedar Hospital, Mugalivakkam Main Road, Porur, Chennai - 600 125, Tamil Nadu
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0019-5154.160511
|
|
|
Vorinostat is a new drug used in the management of cutaneous T cell lymphoma when the disease persists, gets worse or comes back during or after treatment with other medicines. It is an efficacious and well tolerated drug and has been considered a novel drug in the treatment of this condition. Currently apart from cutaneous T cell lymphoma the role of Vorinostat for other types of cancers is being investigated both as mono-therapy and combination therapy. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
